I think Secretary Azar is onto something when he says we ought to disclose what the cost to the patient would be.
Michael Burgess: “I think Secretary Azar is onto something when he says we ought to disclose what the cost to the patient would be.”
Editor's note · Context
Burgess supports transparency in drug pricing for patients.
Share
More from Michael Burgess
By direction of the Committee on Rules, I call up House Resolution 1341 and ask for its immediate consideration. The Clerk read the resolution, as follows: H. Res. 1341 Resolved, That upon adoption of this resolution it shall be in order…
May I inquire as to how much time is remaining. The SPEAKER pro tempore. The gentleman from Texas has 12\1/2\ minutes remaining.
I thank the gentleman for yielding additional time. However, one-sided pressure by the White House is not the way to ensure that end. Mr. Speaker, I urge passage of this rule from our committee, and I urge passage of the underlying…
I led a letter to the FDA asking them to reclassify naloxone to where you could get it without a prescription.





